Dow AgroSciences Acquires PureSpiral(TM) and Multi-Left-Border Technologies

Strategic Insights

Apr 5, 2004 — 1 min read

Dow AgroSciences, a global leader in providing pest management and biotechnology products, has announced the commercial license acquisition of PureSpiral(TM) technology and the Multi-Left-Border technology from Japan Tobacco Inc. This strategic move enables Dow AgroSciences to enhance its capabilities in improving the efficiency of Agrobacterium-mediated transformation. With a workforce of over 5,700 people in more than 50 countries, Dow AgroSciences is committed to improving the quality and quantity of the earth's food supply, contributing to the health and quality of life of the world's growing population. The financial terms of the agreement remain undisclosed.

Key Takeaways:

Dow AgroSciences has acquired a commercial license to PureSpiral(TM) technology and the Multi-Left-Border technology from Japan Tobacco Inc.
The PureSpiral(TM) technology represents a proprietary solution for improving the efficiency of Agrobacterium-mediated transformation.
The Multi-Left-Border Technology is a Japan Tobacco proprietary technology that prevents unexpected vector integration into the plant genome during Agrobacterium-mediated transformation.
Dow AgroSciences has a global presence of over 5,700 people in more than 50 countries and has worldwide sales of more than $3 billion.
The company is a wholly owned indirect subsidiary of The Dow Chemical Company.
Japan Tobacco Inc. is a world-leading manufacturer of tobacco products and has diversified its operations into pharmaceuticals and foods.
The company's net sales were approximately 4.492 trillion yen (approximately $41 million USD) in the fiscal year ended March 31, 2003.

Statistics:

Dow AgroSciences has a workforce of over 5,700 people in more than 50 countries.
The company has worldwide sales of more than $3 billion.
Japan Tobacco Inc.'s net sales were JPY 4.492 trillion yen (approximately $41 million USD) in the fiscal year ended March 31, 2003.

Sources:

PRNewswire, April 6
Japan Tobacco Inc.'s website: http://www.jt.com/

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients